SCHEMBL19259307

SCHEMBL19259307

O=C(O)CCC(NC(=O)N[C@@H](CCS)C(=O)O)C(=O)O

nearest known ligand 0.81

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 9/20 0.81
NAALAD2 Q9Y3Q0 7/20 0.81
RIMKLA Q8IXN7 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12332363 1.00 FOLH1 (0.81) FOLH1NAALAD2RIMKLA
SCHEMBL18636844 1.00 FOLH1 (0.81) FOLH1NAALAD2RIMKLA
SCHEMBL18161468 0.90 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL14102870 0.90 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL12145776 0.90 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL14102890 0.90 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL1377049 0.90 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL1374248 0.89 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL21321511 0.89 FOLH1 (1.00) FOLH1NAALAD2RIMKLA
SCHEMBL19209754 0.89 FOLH1 (1.00) FOLH1NAALAD2RIMKLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2774608-B1 Drug loaded polymeric nanoparticles and methods of making and using same PFIZER (US) 2019-11-20 EP disclosed
EP-2285350-B1 METHODS FOR THE PREPARATION OF TARGETING AGENT FUNCTIONALIZED DIBLOCK COPOLYMERS FOR USE IN FABRICATION OF THERAPEUTIC NANOPARTICLES PFIZER (US) 2017-11-15 EP disclosed
EP-2644594-B1 Cancer Cell Targeting Using Nanoparticles PFIZER (US) 2017-08-23 EP disclosed
WO-2017137953-A1 THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME PFIZER INC. (US) 2017-08-17 WO disclosed